EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents

Colm D Andrews iD, Edward P K Parker, Elsie Horne, Venexia Walker, Tom Palmer, Andrea L Schaffer, Amelia C A Green, Helen J Curtis, Alex J Walker, Lucy Bridges, Christopher Wood, Victoria Speed und 11 weitere

Epidemiology · 2026

DOI: 10.1097/ede.0000000000001908 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Epidemiology, 2026. Verfasst von Colm D Andrews und 22 weiteren Autor:innen. Beteiligte Einrichtung: From the Nuffield Department of Primary Care Health Sciences, Bennett Institute for Applied Data Science, University of Oxford, Oxford, United Kingdo…. Hauptthemen laut MEDLINE: COVID-19, BNT162 Vaccine, COVID-19 Vaccines, Vaccine Efficacy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We assessed the safety and effectiveness of the first- and second-dose BNT162b2 COVID-19 vaccination, offered as part of the national COVID-19 vaccine roll-out from September 2021, in children and adolescents in England.

Methods

Our observational study using OpenSAFELY-TPP, included adolescents aged 12–15 years and children aged 5–11 years. It compared individuals receiving (1) the first vaccination to unvaccinated controls and (2) the second vaccination to single-vaccinated controls. We matched vaccinated individuals with controls on age, sex, and other important characteristics. Outcomes were positive SARS-CoV-2 test (adolescents only), COVID-19 accident and emergency (A&E) attendance, COVID-19 hospitalization, COVID-19 critical care admission, and COVID-19 death; with safety outcomes, A&E attendance, unplanned hospitalization, pericarditis, and myocarditis.

Results

Among 820,926 previously unvaccinated adolescents, 20-week incidence rate ratios (IRRs) comparing vaccination with no vaccination were 0.74 for positive SARS-CoV-2 test, 0.60 for COVID-19 A&E attendance, and 0.58 for COVID-19 hospitalization. Among 441,858 adolescents who had received the first vaccination, IRRs comparing second dose with single-vaccination were 0.67 for positive SARS-CoV-2 test, 1.00 for COVID-19 A&E attendance, and 0.60 for COVID-19 hospitalization. In both children groups, COVID-19-related outcomes were too rare to allow IRRs to be estimated precisely. Across all analyses, there were no COVID-19-related deaths, and fewer than seven COVID-19-related critical care admissions. Myocarditis and pericarditis were documented only in the vaccinated groups, with rates of 27 and 10 cases/million after the first and second doses, respectively.

Conclusions

BNT162b2 vaccination in adolescents reduced COVID-19 A&E attendance and hospitalization, although these outcomes were rare. Protection against positive SARS-CoV-2 tests was transient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BNT162 VaccineCOVID-19 VaccinesVaccine EfficacyVaccinationHumansChildAdolescentFemaleMaleEnglandSARS-CoV-2HospitalizationChild, Preschool

Stichwörter der Autor:innen

COVIDCoronavirusEpidemiologyPandemicsPediatricsVaccines

Substanzen

BNT162 VaccineCOVID-19 Vaccines

Autor:innen und Institutionen

  • From the Nuffield Department of Primary Care Health Sciences, Bennett Institute for Applied Data Science, University of Oxford, Oxford, United Kingdom.
  • London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • TPP, TPP House, Leeds, United Kingdom.
  • Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.

ORCID-Profile: Colm D Andrews

Förderung

  • Wellcome Trust

Zitieren

APA

Andrews, C. D., Parker, E. P. K., Horne, E., Walker, V., Palmer, T., Schaffer, A. L., Green, A. C. A., Curtis, H. J., Walker, A. J., Bridges, L., Wood, C., Speed, V., Bates, C., Cockburn, J., Parry, J., Mehrkar, A., MacKenna, B., Bacon, S. C. J., Goldacre, B., …, & OpenSAFELY Collaborative (2026). OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents. Epidemiology. https://doi.org/10.1097/ede.0000000000001908

Vancouver

Andrews CD, Parker EPK, Horne E, Walker V, Palmer T, Schaffer AL, et al. OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents. Epidemiology. 2026. doi:10.1097/ede.0000000000001908

BibTeX
@article{Andrews2026,
  author = {Andrews, Colm D and Parker, Edward P K and Horne, Elsie and Walker, Venexia and Palmer, Tom and Schaffer, Andrea L and Green, Amelia C A and Curtis, Helen J and Walker, Alex J and Bridges, Lucy and Wood, Christopher and Speed, Victoria and Bates, Christopher and Cockburn, Jonathan and Parry, John and Mehrkar, Amir and MacKenna, Brian and Bacon, Sebastian C J and Goldacre, Ben and Hernan, Miguel A and Sterne, Jonathan A C and Hulme, William J and OpenSAFELY Collaborative, OpenSAFELY Collaborative},
  title = {OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents},
  journal = {Epidemiology},
  year = {2026},
  doi = {10.1097/ede.0000000000001908}
}
Kostenlos starten →